Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

NCT00881582 is registered in ClinicalTrials.gov with King Abdulaziz Medical City as lead sponsor.

NCT NCT00881582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00881582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients
Lead sponsor
King Abdulaziz Medical City
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, renal transplant